Found: 5
Select item for more details and to access through your institution.
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 4, p. 236, doi. 10.3390/metabo11040236
- By:
- Publication type:
- Article
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 988, doi. 10.1111/dom.13990
- By:
- Publication type:
- Article
Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 1, p. 159, doi. 10.2337/dc14-0769
- By:
- Publication type:
- Article
Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome.
- Published in:
- Nutrients, 2024, v. 16, n. 12, p. 1822, doi. 10.3390/nu16121822
- By:
- Publication type:
- Article
Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
- Published in:
- Nutrients, 2020, v. 12, n. 8, p. 2308, doi. 10.3390/nu12082308
- By:
- Publication type:
- Article